Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Completed · Not applicable

Conditions studied: GARDASIL Vaccination

In brief

Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.

Key facts

Study ID

NCT01343485

Run by

Planned Parenthood Federation of America

People needed

365

Starts

2011-09-01

Expected to finish

2012-10-01

Last updated by the study team

2018-06-26

Who can join

Age: 19 and older, up to 26. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female;
• Age 19-26;
• Fluent in English;
• Seeking services for anything except pregnancy or abortion on the day of the visit
• No previous vaccinations for HPV
• No contraindication for HPV vaccine (includes a severe allergic reaction to yeast, amorphous aluminum hydroxyphosphate sulfate, and polysorbate 80.)
• Access to phone, text, mail, email, or facebook
• Not wanting to become pregnant in the next 8 months;
• Not planning on moving from the area in the next 8 months
• Willing to be contacted for follow-up over the next 8 months.

You may not qualify if…

• Women below 19 or above 26.
• Male
• Women who have one or more of HPV vaccination.
• Women who have a contraindication for HPV vaccine.
• Women who do not have access by phone, mail, email, Twitter or Facebook for follow up.
• Women who are not fluent in English
• Pregnant women or those intending on becoming pregnant during the study period.
• Women who will be moving from the area and unable to return for follow up over the course of the study (approximately 8 months).
• Severe mental impairment and unable to give Informed Consent.

Where it is running

• Planned Parenthood of Arizona — Glendale, Arizona, United States
• Planned Parenthood of Rocky Mountains — Arvada, Colorado, United States
• Planned Parenthood of Rocky Mountains — Denver, Colorado, United States
• Family Planning Clinic of the John H. Stroger Jr. Hospital of Cook County — Chicago, Illinois, United States
• Planned Parenthood of Central North Carolina — Chapel Hill, North Carolina, United States
• Planned Parenthood of North Carolina — Charlotte, North Carolina, United States
• Planned Parenthood Association of Utah — Ogden, Utah, United States
• Planned Parenthood Association of Utah — South Jordan, Utah, United States
• Planned Parenthood of Greater Northwest — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.